Author

Rohit Sivaprasad

Lund UniversityORCID 0009-0002-8303-7150Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Agatheeswaran SubramaniamiD· 1 shared Anne de Snaijer· 1 shared David Linfeldt· 1 shared Fredrik EkiD· 1 shared Jenny HanssoniD· 1 shared Kristijonas ŽemaitisiD· 1 shared Mattias MagnussoniD· 1 shared Sudip GhoshiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Agatheeswaran SubramaniamORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer Gene TherapyPeer-reviewedAug 10, 2026

Cancer-associated KBTBD4 mutations induce differentiation defects and confer a unique therapeutic vulnerability

Rohit Sivaprasad, Kristijonas Žemaitis, David Linfeldt…·Agatheeswaran Subramaniam

This study models KBTBD4 mutations in hematopoietic stem cells, identifies HDAC inhibitors as therapeutic agents, and reveals their mechanism of action.

DOI 10.1038/s41417-026-01068-x

humanbulk RNA-seq